Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AFFYMAX INC | 76,666 | reported | 28 Jun 2013 | tx 53+1,253,953−494,240 |
| ANAPTYSBIO, INC | 16,510 | reported | 20 Apr 2026 | tx 28+145,022−65,846 |
| First Tracks Biotherapeutics, Inc. | 15,000 | reported | 12 May 2026 | tx 10+125,511 |
| Travere Therapeutics, Inc. | 12,000 | reported | 19 May 2026 | tx 20+166,375 |
| NeurogesX Inc | 10,000 | reported | 07 Jun 2012 | tx 5+100,000 |
| Atreca, Inc. | 1 | reported | 11 Apr 2024 | tx 17+2,026,150−752,608 |
| CARGO Therapeutics, Inc. | 0 | reported | 19 Aug 2025 | tx 5+73,742−40,865 |
| Relypsa Inc | 0 | reported | 01 Sept 2016 | tx 47+461,805−1,293,237 |
| SEATTLE GENETICS INC /WA | 0 | reported | 14 Dec 2023 | tx 31+97,934−97,934 |
| ARRAY BIOPHARMA INC | 0 | reported | 30 Jul 2019 | tx 25+185,000−205,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 42,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 8,250 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 8,250 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 3,311 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 3,311 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 3,311 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 8,250 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 1,300 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 6,030 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 06 Jan 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 6,000 | 0.00 USD | deriv |
| 06 Jan 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 8,250 | 0.00 USD | deriv |
| 15 Sept 2025 | EXERCISE | ANAPTYSBIO, INC | 1,300 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 11 Apr 2024.